[Treatment of disorders in interferon status of patients with urogenital chlamydial infection].
The interferon status was studied in 54 patients with urogenital chlamydiosis, presenting with disturbances in the reproductive system. The blood serum content of gamma-interferon was 32-fold in the above patient population vs control subjects on conventional therapy. Supplementing such a therapy with cycloferon, an inducer of endogenous interferon, and with immunomodulin have been shown to activate production of interferon.
Abidov
A M
AM
Saĭitkulov
A M
AM
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use*; D002690:Chlamydia Infections / Q000188:drug therapy / Q000276:immunology*; D052776:Female Urogenital Diseases / Q000188:drug therapy / Q000276:immunology* / Q000382:microbiology; D006801:Humans; D007273:Injections, Intramuscular; D016898:Interferon-alpha / Q000096:biosynthesis / Q000276:immunology; D007371:Interferon-gamma / Q000096:biosynthesis / Q000276:immunology; D007372:Interferons / Q000096:biosynthesis* / Q000276:immunology; D052801:Male Urogenital Diseases; D009930:Organic Chemicals
D000276:Adjuvants, Immunologic; D016898:Interferon-alpha; D009930:Organic Chemicals; C404023:immunomodulin; D007371:Interferon-gamma; D007372:Interferons